Skip to main content


Fig. 1 | BMC Musculoskeletal Disorders

Fig. 1

From: Developing an animal model of Dupuytren’s disease by orthotopic transplantation of human fibroblasts into athymic rat

Fig. 1

Lipophilic cell tracer DiR® does not affect fibroblast proliferative capacity. Cell viability and proliferative capacity of Vybrant DiR® labeled and unlabeled CT- and DD-derived fibroblasts was compared in vitro. No significant difference was observed in viability or proliferative capacity between the labeled and unlabeled cell populations for both CT- and DD-cells at either 30 min or 24 h. Studies were performed on four independent cultures obtained from each of the cell types; values are mean ± SEM of two separate experiments performed in triplicate

Back to article page